← Leaderboards
Elizabeth Munding
Cantata Bio Llc
$1,993,708
Attributed
$1,993,708
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2024–25$2M$1.5M$1M$500K$0
'24
'25
Funding mix
By agency
NIH$1,993,708 · 1
By mechanism
R44$1,993,708 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Actionable Mutation”
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Robert W Cross · University Of Texas Med Br Galveston$4,640,498
- Seunghee Kim-Schulze · Icahn School Of Medicine At Mount Sinai$2,933,846
- Raul Padron · Univ Of Massachusetts Med Sch Worcester$2,818,630
- Nicholas Schafer · Constantiam Biosciences Inc.$2,445,923
- Alison F Feder · University Of Washington$2,326,574
Research focus
Actionable MutationAdoptionAffectAutomationAutomobile DrivingBenchmarkingBloodCancer DetectionCancer DiagnosisCancer DiagnosticsCancer GenomicsCancer PatientCancer TypeCausal VariantCause Of DeathCessation Of LifeClinical ApplicationClinically RelevantClinical OncologyCommercial ApplicationCommercializationCommercial LaunchComplexAccounting
Grant awards (2)
Commercialization of a rapid, automated Hi-C platform for sensitive genomic profiling of multiple cancer sample types$746,680
R44 · FY2025 · HG · contact PI
Commercialization of a rapid, automated Hi-C platform for sensitive genomic profiling of multiple cancer sample types$1,247,028
R44 · FY2024 · HG · contact PI